MIRA INFORM REPORT

 

 

Report No. :

349565

Report Date :

18.11.2015

 

IDENTIFICATION DETAILS

 

Name :

TELEFLEX MEDICAL EUROPE LIMITED

 

 

Formerly Known as :

TELEFLEX SERVICES EUROPE LIMITED

 

 

Registered Office :

IDA Business Park Athlone Co Westmeath 28406

 

 

Country :

Ireland

 

 

Financials (as on) :

31.12.2013

 

 

Date of Incorporation :

19.10.2006

 

 

Legal Form :

Limited Company

 

 

Line of Business :

·         Management Consultancy Activities Other Than Financial Management.

·         Manufacture, sales and distribution of disposable medical devices produced by group companies and the provision of management services to related group companies.

 

 

No. of Employee :

293

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Ireland

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

IRELAND ECONOMIC OVERVIEW

 

Ireland is a small, modern, trade-dependent economy. Ireland was among the initial group of 12 EU nations that began circulating the euro on 1 January 2002. GDP growth averaged 6% in 1995-2007, but economic activity dropped sharply during the world financial crisis and the subsequent collapse of its domestic property market and construction industry. Faced with sharply reduced revenues and a burgeoning budget deficit from efforts to stabilize its fragile banking sector, the Irish Government introduced the first in a series of draconian budgets in 2009. These measures were not sufficient to stabilize Ireland’s public finances. In 2010, the budget deficit reached 32.4% of GDP - the world's largest deficit, as a percentage of GDP. In late 2010, the former COWEN government agreed to a $92 billion loan package from the EU and IMF to help Dublin recapitalize Ireland’s banking sector and avoid defaulting on its sovereign debt. In March 2011, the KENNY government intensified austerity measures to meet the deficit targets under Ireland's EU-IMF bailout program. In late 2013, Ireland formally exited its EU-IMF bailout program, benefiting from its strict adherence to deficit-reduction targets and success in refinancing a large amount of banking-related debt. In 2014, the economy rapidly picked up and GDP grew by 3.6%. The recovering economy assisted lowering the deficit to 4.2% of GDP. In late 2014, the government introduced a fiscally neutral budget, marking the end of the austerity program. In the wake of the collapse of the construction sector and the downturn in consumer spending and business investment, the export sector, dominated by foreign multinationals, has become an even more important component of Ireland's economy. Ireland’s low corporation tax of 12.5% has been central to encouraging business investment. Loose tax residency requirements made Ireland a common destination for international firms seeking to avoid taxation. Amid growing international pressure the government announced it would phase in more stringent tax laws, effectively closing a loophole.

 

Source : CIA

 

 

 

 


Company Summary

 

Registered Address

IDA BUSINESS PARK

ATHLONE CO WESTMEATH

28406

Trading Address

 

AF4 Athlone Business &

Technology Garrycastle Dublin Road Athlone Co Westmeath 999934

Website Address

--

 

 

Telephone Number

 

Fax Number

 

TPS

No

FPS

No

Incorporation Date

19/10/2006

 

 

Previous Name

TELEFLEX SERVICES EUROPE LIMITED

Type

Other

FTSE Index

--

Date of Change

--

Filing Date of Accounts

--

Currency

EUR

Share Capital

€551,239

SIC07

70229

Charity Number

--

 

 

SIC07 Description

MANAGEMENT CONSULTANCY ACTIVITIES OTHER THAN FINANCIAL MANAGEMENT

Principal Activity

The manufacture, sales and distribution of disposable medical devices produced by group companies and the provision of management services to related group companies.

 

 

Key Financials

 

Year to Date

Turnover

Pre Tax Profit

Shareholder

Funds Employees

31/12/2013

€390,791,000

€28,051,000

€34,272,000

293

31/12/2012

€326,165,000

€23,807,000

€69,223,000

252

31/12/2011

€288,538,000

€28,922,000

€61,607,000

253

 

 

Commentary

 

No exact match CCJs are recorded against the company.

Sales in the latest trading period increased 19.8% on the previous trading period.

Pre-tax profits increased by 17.8% compared to the previous trading period.

The audit report contains no adverse comments.

 

 

CJ

 

Total Number of Exact CJs                  - 0                    Total Value of Exact CJs          - €0

Total Number of Possible CJs              - 0                    Total Value of Possible CJs     - €0

Total Number of Satisfied CJs             - 0                    Total Value of Satisfied CJs     - €0

 

 

Total Current Directors                            3

Total Current Secretaries                        1

Total Previous Directors / Company

Secretaries                                            5

 

 

Current Directors

 

Name

GERARD  DANIEL  MCCAFFREY    Date  of  Birth

 

22/10/1954

Officers  Title

 

Nationality

 

Present  Appointments

2

Function

Director

Appointment  Date

01/10/2008

 

 

Address

6 EARLSFORT,  MOIRA,  DOWN,  NORTHERN  IRELAND  BT67  OLY

Name

LIAM  KELLY

Date  of  Birth

16/04/1966

Officers  Title

 

Nationality

 

Present  Appointments

1

Function

Director

Appointment  Date

01/12/2009

 

 

Address

KILN  LODGE,  QUAY  LANE,  BALLINA,  CO  MAYO

Name

MONIKA  VIKANDER-HEGARTY    

Date  of  Birth

24/10/1965

Officers  Title

 

Nationality

 

Present  Appointments

1

Function

Director

Appointment  Date

17/12/2010

 

 

Address

9 ROGERSTOWN  PARK,  SOUTH  SHORE  PARK,  RUSH,  CO.DUBLIN

 

 

Current Company Secretary

 

Name

GERARD  DANIEL  MCCAFFREY   

Date  of  Birth

22/10/1954

Officers  Title

 

Nationality

 

Present  Appointments

2

Function

Company  Secretary

Appointment  Date

01/02/2007

 

 

Address

6 EARLSFORT,  MOIRA,  DOWN,  NORTHERN  IRELAND  BT67  OLY

 

 

Top 20 Shareholders

 

Name

Currency

Share  Count

Share  Type

Nominal  Value

% of  Total  Share  Count

TELEFLEX  LIFE  SCIENCES

EUR

551,239

ORDINARY

1

100

 

 

Profit & Loss

 

Date of Accounts

31/12/13

(%)

31/12/12

(%)

31/12/11

(%)

31/12/10

(%)

31/12/09

Weeks

52

(%)

52

(%)

52

(%)

52

(%)

52

Currency

EUR

(%)

EUR

(%)

EUR

(%)

EUR

(%)

EUR

Consolidated A/cs

N

(%)

N

(%)

N

(%)

N

(%)

N

Turnover

€390,791,000

19.8%

€326,165,000

13%

€288,538,000

22.4%

€235,789,000

103.6%

€115,801,000

Export

-

-

-

-

-

-

-

-

-

Cost  of  Sales

€274,374,000

19.2%

€230,178,000

12.5%

€204,515,000

14.4%

€178,741,000

117.8%

€82,081,000

Gross  Profit

€116,417,000

21.3%

€95,987,000

14.2%

€84,023,000

47.3%

€57,048,000

69.2%

€33,720,000

Wages  &

Salaries

€37,597,000

21.7%

€30,889,000

16.3%

€26,568,000

89.6%

€14,016,000

19.7%

€11,709,000

Directors Emoluments

€1,127,000

10.2%

€1,023,000

33.4%

€767,000

-13.6%

€888,000

-

-

Operating  Profit

€46,714,000

16.7%

€40,027,000

33.2%

€30,050,000

58.8%

€18,925,000

37.2%

€13,790,000

Depreciation

€1,093,000

30.1%

€840,000

19.1%

€705,000

206.5%

€230,000

18.6%

€194,000

Audit  Fees

€210,000

22.8%

€171,000

-

€171,000

17.9%

€145,000

93.3%

€75,000

Interest  Payments

€18,749,000

240.6%

€5,505,000

397.7%

€1,106,000

29.4%

€855,000

352.4%

€189,000

Pre  Tax  Profit

€28,051,000

17.8%

€23,807,000

-17.7%

€28,922,000

60.9%

€17,979,000

31.9%

€13,634,000

Taxation

-€3,118,000

23.5%

-€4,078,000

-10.2%

-€3,701,000

-54.4%

-€2,397,000

-40.5%

-€1,706,000

Profit  After  Tax

€24,933,000

26.4%

€19,729,000

-21.8%

€25,221,000

61.9%

€15,582,000

30.6%

€11,928,000

Dividends

€61,002,000

369.2%

€13,000,000

-

-

-100%

€10,000,000

-

-

Payable

Retained  Profit

-€36,069,000

-636%

€6,729,000

-73.3%

€25,221,000

351.8%

€5,582,000

-53.2%

€11,928,000

 

 

Balance Sheet

 

Date of Accounts

31/12/13

(%)

31/12/12

(%)

31/12/11

(%)

31/12/10

(%)

31/12/09

Weeks

52

(%)

52

(%)

52

(%)

52

(%)

52

Currency

EUR

(%)

EUR

(%)

EUR

(%)

EUR

(%)

EUR

Consolidated A/cs

N

(%)

N

(%)

N

(%)

N

(%)

N

Tangible  Assets Intangible

€200,271,000

0.3%

€199,667,000

999.9%

€4,019,000

753.3%

€471,000

-9.2%

€519,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Intangible

Assets

€6,881,000

-28.2%

€9,583,000

108.4%

€4,599,000

-

0

-

0

Total  Fixed Assets

€207,152,000

-1%

€209,250,000

999.9%

€8,618,000

999.9%

€471,000

-9.2%

€519,000

Stock

€52,700,000

1.4%

€51,980,000

2.8%

€50,547,000

23.9%

€40,811,000

96.4%

€20,777,000

Trade  Debtors

€16,224,000

14.2%

€14,203,000

-2.9%

€14,632,000

53.9%

€9,508,000

18.4%

€8,028,000

Cash

€28,204,000

-28.9%

€39,678,000

21.3%

€32,722,000

74.1%

€18,800,000

-1.8%

€19,147,000

Other  Debtors

€34,800,000

-29.2%

€49,121,000

-2.3%

€50,273,000

34%

€37,508,000

94.4%

€19,294,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Miscellaneous

Current Assets

0

-

0

-

0

-

0

-

0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Current

Assets

€131,928,000

-14.9%

€154,982,000

4.6%

€148,174,000

39%

€106,627,000

58.6%

€67,246,000

Trade Creditors

€7,341,000

0.4%

€7,311,000

-9.3%

€8,064,000

4.6%

€7,712,000

180.6%

€2,748,000

Bank Loans &

Overdrafts

0

-

0

-

0

-

0

-

-

Other Short Term

Finance

€53,769,000

30%

€41,357,000

-9%

€45,447,000

35.3%

€33,590,000

105.2%

€16,373,000

Miscellaneous

Current

Liabilities

€6,450,000

12.2%

€5,750,000

25.8%

€4,569,000

-2.7%

€4,697,000

117.3%

€2,162,000

Total Current

Liabilities

€67,560,000

24.2%

€54,418,000

-6.3%

€58,080,000

26.3%

€45,999,000

116.1%

€21,283,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bank Loans &

Overdrafts and

LTL

€237,248,000

-1.4%

€240,591,000

548.4%

€37,105,000

-1%

€37,477,000

25.6%

€29,834,000

Other Long Term

Finance

€237,248,000

-1.4%

€240,591,000

548.4%

€37,105,000

-1%

€37,477,000

25.6%

€29,834,000

 

 

 

 

 

 

 

 

 

 

Total Long Term

Liabilities

€237,248,000

-1.4%

€240,591,000

548.4%

€37,105,000

-1%

€37,477,000

25.6%

€29,834,000

 

 

Capital & Reserves

 

Date of Accounts

31/12/13

(%)

31/12/12

(%)

31/12/11

(%)

31/12/10

(%)

31/12/09

 

 

 

 

 

 

 

 

 

 

Weeks

52

(%)

52

(%)

52

(%)

52

(%)

52

Currency

EUR

(%)

EUR

(%)

EUR

(%)

EUR

(%)

EUR

Consolidated A/cs

N

(%)

N

(%)

N

(%)

N

(%)

N

Called Up Share

Capital

€535,000

-

€535,000

-

€535,000

7%

€500,000

-

€500,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

P & L Account

Reserve

€17,169,000

-68%

€53,618,000

14.4%

€46,889,000

116.4%

€21,668,000

35.5%

€15,988,000

Revaluation

Reserve

--

--

--

--

--

--

--

--

--

Sundry Reserves

€16,568,000

9.9%

€15,070,000

6.3%

€14,183,000

875.4%

€1,454,000

808.8%

€160,000

Shareholder Funds

€34,272,000

-50.5%

€69,223,000

12.4%

€61,607,000

160.8%

€23,622,000

41.9%

€16,648,000

 

 

Other Financial Items

 

Date Of Accounts

31/12/13

(%)

31/12/12

(%)

31/12/11

(%)

31/12/10

(%)

31/12/09

Net Worth

€27,391,000

-54.1%

€59,640,000

4.6%

€57,008,000

141.3%

€23,622,000

41.9%

€16,648,000

Working Capital

€64,368,000

-36%

€100,564,000

11.6%

€90,094,000

48.6%

€60,628,000

31.9%

€45,963,000

Total Assets

€339,080,000

-6.9%

€364,232,000

132.3%

€156,792,000

46.4%

€107,098,000

58%

€67,765,000

Total Liabilities

€304,808,000

3.3%

€295,009,000

209.9%

€95,185,000

14%

€83,476,000

63.3%

€51,117,000

Net Assets

€34,272,000

-50.5%

€69,223,000

12.4%

€61,607,000

160.8%

€23,622,000

41.9%

€16,648,000

 

 

Miscellaneous

 

Date Of Accounts

31/12/13

(%)

31/12/12

(%)

31/12/11

(%)

31/12/10

(%)

31/12/09

Contingent Liability

YES

-

YES

-

YES

-

YES

-

NO

Capital Employed

€271,520,000

-12.4%

€309,814,000

213.9%

€98,712,000

61.6%

€61,099,000

31.4%

€46,482,000

Number of Employees

293

16.3%

252

-0.4%

253

86%

136

72.2%

79

 

 

Auditors

PRICEWATERHOUSECOOPERS

Auditor Comments

The audit report contains no adverse comments

Bankers

BANK OF IRELAND

Bank Branch Code

90-16-34

 

 

Ratios

 

Date Of Accounts

31/12/13

31/12/12

31/12/11

31/12/10

31/12/09

Pre-tax profit margin %

7.18

7.30

10.02

7.63

11.77

Current ratio

1.95

2.85

2.55

2.32

3.16

Sales/Net Working Capital

6.07

3.24

3.20

3.89

2.52

Gearing %

692.30

347.60

60.20

158.70

179.20

Equity in %

10.30

19.50

40.50

22.10

24.60

Creditor Days

6.83

8.15

10.17

11.90

8.63

Debtor Days

15.11

15.85

18.45

14.67

25.23

Liquidity/Acid Test

1.17

1.89

1.68

1.43

2.18

Return On Capital Employed %

10.33

7.68

29.29

29.42

29.33

Return On Total Assets Employed %

8.27

6.53

18.44

16.78

20.11

Current Debt Ratio

1.97

0.78

0.94

1.94

1.27

Total Debt Ratio

8.89

4.26

1.54

3.53

3.07

Stock Turnover Ratio %

13.48

15.93

17.51

17.30

17.94

Return on Net Assets Employed %

81.84

34.39

46.94

76.11

81.89

 

 

Report Notes

 

There are no notes to display.

 

 

Status History

 

No Status History found

 

 

Event History

 

Date

Description

19/12/2014

New  Accounts  Filed

18/12/2014

Annual  Returns

27/11/2013

Annual  Returns

27/11/2013

New  Accounts  Filed

29/11/2012

New  Accounts  Filed

28/11/2012

Annual  Returns

10/12/2011

Annual  Returns

10/12/2011

New  Accounts  Filed

08/12/2011

Annual  Returns

07/12/2011

New  Accounts  Filed

07/12/2011

New  Accounts  Filed

22/06/2011

WILLIAM  BARRY  MCBRIDE  has  left  the  board

17/12/2010

New  Board  Member  (MONIKA  VIKANDER-HEGARTY)  appointed

28/10/2010

New  Accounts  Filed

28/10/2010

New  Accounts  Filed

 

 

Previous Company Names

 

Date

 

 

Previous  Name

N/A

 

TELEFLEX  SERVICES  EUROPE  LIMITED

 

 

RECEIVED  DOCUMENTS

 

Writ Details

 

No writs found

 

 

Statistics

 

Group

7 companies

Linkages

238 companies

Countries

In  37  countries

 

 

Summary

 

Holding  Company

TELEFLEX  LIFE  SCIENCES

Ownership  Status

Wholly  Owned

Ultimate  Holding  Company

TELEFLEX  INCORPORATED

 

 

Group Structure

 

Company Name

Registered

Number

Latest Key

Financials

Consol.

Accounts

Turnover

 

 

 

 

 

TELEFLEX  INCORPORATED

 

-

-

 

ITAL  HANDLING  SPA

N/A

-

-

 

TELEFLEX  LIFE  SCIENCES

IE509459

31.12.2013

N

€698,000

TELEFLEX  MEDICAL  E...

IE428329

31.12.2013

N

€390,791,000

INTAVENT  DIRECT  LTD

06934202

31.12.2014

 

 

REUSCH  AUSTRIA  GMBH

N/A

-

-

 

TFX  GROUP  LIMITED

02884361

31.12.2014

N

£28,527,000

 

 

BUSINESS  OWNER  LINKS

 

 

 

Business  Name

 

Business  No

Business  Status.

TELEFLEX  MEDICAL  EUROPE  LIMITED

IE428329

 

LMA  THE  LARYNGEAL  MASK

493247

NORMAL

INMED

469501

NORMAL

ICOR

469499

NORMAL

TELEFLEX MEDICAL

434949

NORMAL

TELEFLEX

469500

NORMAL

 

 

 

 

 

 

 

 

 

 

 

 

OTHER LINKED COMPANIES

 

Name

 

Latest  Key  Financials  

Turnover

WILLY  RÜSCH  GMBH

 

€16,860,468

TFX  INTERNATIONAL

31.12.2013

 

TELAIR  INTERNATIONAL  GMBH

31.05.2014

€113,006,000

TELEFLEX  MEDICAL

31.12.2013

€53,778,659

SOMETEC  HOLDINGS  SAS

31.08.2014

 

COMPART  AUTOMOTIVE  B.V.

31.12.2011

 

TELAIR  INTERNATIONAL  AB

 

8,500 KSEK  104,825  KSEK

ROSTI  MCKECHNIE  LTD

31.12.2013

£95,621,000

MAL  TOOL  &  ENGINEERING LIMITED

31.12.2003

 

SERMATECH  (U.K.)  LIMITED

31.12.2008

 

ASTRAFLEX  LIMITED

31.12.2011

 

RMH  CONTROLS  LIMITED

31.12.2008

 

INTELLIGENT  APPLICATIONS  LIMITED

31.12.2008

 

SERMATECH  (GERMANY)  GMBH

-

 

MEDICAL  SERVICE  VERTRIEBS-GMBH

 

 

TELAIR  INTERNATIONAL  SERVICES  GMBH

-

 

BAVARIA  CARGO  TECHNOLOGIE  GMBH

-

 

TELEFLEX  AUTOMOTIVE  GERMANY  GMBH

 

 

HUMMINBIRD

-

$60,000,000

TELEFLEX  MEDICAL  INCORPORATED

-

 

 

 

Previous Director/Company Secretaries

 

Name

Current  Directorships

Previous  Directorships

NOREEN  KENNY

168

944

NOREEN  KENNY

168

944

OSKAR  ZAHN

0

1

WILLIAM  BARRY  MCBRIDE

0

1

JAMES  KENNY

12

91

 

 

Average Invoice Value

€1760.01

Invoices available

195

Paid

188

Outstanding

7

 

Trade Payment Data is information that we collect from selected third party partners who send us information about their whole sales ledger.

 

 

 

 

Within Terms

0-30 Days

31-60 Days

61-90 Days

91+ Days

Paid

43

95

35

4

11

Outstanding

0

3

2

0

2

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.65.98

UK Pound

1

Rs.100.11

Euro

1

Rs.70.35

 

 

INFORMATION DETAILS

 

Analysis Done by :

KAS

 

 

Report Prepared by :

ANK

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.